Koyfin Home > Directory > Health Care > Akebia Therapeutics > Net Debt / (EBITDA-CAPEX)

Akebia Therapeutics Net Debt / (EBITDA-CAPEX) Chart (AKBA)

Akebia Therapeutics annual/quarterly Net Debt / (EBITDA-CAPEX) from 2012 to 2020.
  • Akebia Therapeutics Net Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $3m a 59.57% increase of 2m year over year
  • Akebia Therapeutics Net Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $1m a 48.43% increase of 1m year over year
  • Akebia Therapeutics Annual Net Debt / (EBITDA-CAPEX) for 2019 was $0m a -786.51% decrease of -2m from 2018
  • Akebia Therapeutics Annual Net Debt / (EBITDA-CAPEX) for 2018 was $2m a -99.42% decrease of -2m from 2017
  • Akebia Therapeutics Annual Net Debt / (EBITDA-CAPEX) for 2017 was $4m a 54.16% increase of 2m from 2016
Other Ratios Metrics:
  • Akebia Therapeutics Total Debt / Capital for the quarter ending December 12, 2018 was $2m a 99.29% increase of 2m year over year
  • Akebia Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $95m a 0.76% increase of 1m year over year
  • Akebia Therapeutics Total Debt / Equity for the quarter ending December 12, 2018 was $2m a 99.31% increase of 2m year over year
View Chart On Koyfin

Quarterly AKBA Net Debt / (EBITDA-CAPEX) Data

06/2020$3m
03/2020$0m
12/2019$0m
09/2019$1m
06/2019$1m
03/2019$1m
12/2018$1m
09/2018$3m
06/2018$3m
03/2018$4m

Annual AKBA Net Debt / (EBITDA-CAPEX) Data

2019$0m
2018$2m
2017$4m
2016$2m
2015$2m
2014$3m
2013$2m
2012$0m
2011$0m